跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
安素泰 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Paclitaxel Injection
Approved
化学药品
Paclitaxel Injection
PFIZER AUSTRALIA PTY LTD
🇨🇳 National Medical Products Administration
Approval Date
Nov 4, 2024
Approval ID
8enLwYuDgZW
Company
PFIZER AUSTRALIA PTY LTD
Type
化学药品
Approval Details
Approval Id
8enLwYuDgZW
Approval Number
国药准字HJ20150350
Generic Name
紫杉醇注射液
Generic Name En
Paclitaxel Injection
Trade Name
安素泰
Drug Type
化学药品
Dosage Form
注射剂
Strength
5ml:30mg
Reg Date
2024-11-04
Expired Date
2029-11-03
Company Name
PFIZER AUSTRALIA PTY LTD
Production Company Name
HOSPIRA AUSTRALIA PTY LTD
Company Detail Path
/organization/pfizer-australia-pty-ltd
Production Company Detail Path
/organization/hospira-australia-pty-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 4, 2024
Approval ID
8enLwYuDgZW
Type
化学药品
Back to NMPA Approvals